Kloosterman Esteban Martin, Rosman Jonathan Z, Berkowitz Eric J, Rosenbaum Murray, Wettenstein Zachary
Cardiac Arrhythmia Service, Boca Raton, FL, USA.
Florida Atlantic University, Boca Raton, FL, USA.
J Innov Card Rhythm Manag. 2023 Feb 15;14(2):5348-5354. doi: 10.19102/icrm.2023.14024. eCollection 2023 Feb.
Remote control (RC) of cardiac implantable electronic devices (CIEDs) has been tested as safe and effective in the magnetic resonance imaging space. We sought to evaluate RC applications of patients at home. RC of cardiac devices in patients' homes is feasible, safe, and effective, with consistent patient satisfaction. Patients with CIEDs using the CareLink™ network (Medtronic, Minneapolis, MN, USA) participated in a pair of home RC sessions. A technician visited the patient's house and set up a telehealth tablet and a programmer, which included inputting a session key enabling programmer access via a third-party host. The investigator video-conferenced with the patient and remotely controlled the programmer for device testing and data assessment, using a cellular hotspot for Internet connection. Reprogramming was performed as necessary. In all cases, an RC session legend was programmed in the device information field as a control. The patients then completed an experience questionnaire. One hundred fifty patients (99 pacemakers and 51 implantable cardioverter-defibrillators) completed 2 RC sessions, for 300 RC sessions in total. There were no complications or communication interruptions once the system communication proved stable after the first minute. In 26 sessions, initial communication was interrupted upon device interrogation, requiring communication to be re-established (which sometimes necessitated switching to an alternative carrier). Clinically driven parameter reprogramming was performed in 58 RC sessions (39%). Programming of notations concerning RC sessions was performed in all 300 sessions. The average duration of the RC sessions was 11 min. Patients' satisfaction scored 4.5 out of 5 points. In conclusion, RC management of cardiac devices at patients' homes is safe, effective, convenient, and associated with high patient satisfaction. This technology may prove very useful in a changing health care delivery system, especially amid the coronavirus disease 2019 pandemic.
心脏植入式电子设备(CIED)的远程控制(RC)已在磁共振成像空间中被测试为安全有效。我们试图评估在家中患者的RC应用情况。在患者家中对心脏设备进行RC是可行、安全且有效的,患者满意度一致。使用CareLink™网络(美敦力公司,明尼阿波利斯,明尼苏达州,美国)的CIED患者参加了一对家庭RC会话。一名技术人员前往患者家中并设置了远程医疗平板电脑和编程器,这包括输入一个会话密钥,以便通过第三方主机访问编程器。研究人员与患者进行视频会议,并使用蜂窝热点进行互联网连接,远程控制编程器进行设备测试和数据评估。必要时进行重新编程。在所有情况下,在设备信息字段中编入一个RC会话图例作为对照。然后患者完成一份体验问卷。150名患者(99台起搏器和51台植入式心律转复除颤器)完成了2次RC会话,总共进行了300次RC会话。在第一分钟后系统通信稳定后,没有出现并发症或通信中断。在26次会话中,设备询问时初始通信中断,需要重新建立通信(有时需要切换到备用运营商)。在58次RC会话(39%)中进行了临床驱动的参数重新编程。在所有300次会话中都进行了关于RC会话的注释编程。RC会话的平均持续时间为11分钟。患者满意度得分为4.5分(满分5分)。总之,在患者家中对心脏设备进行RC管理是安全、有效、方便的,并且患者满意度高。这项技术在不断变化的医疗保健提供系统中可能会被证明非常有用,尤其是在2019冠状病毒病大流行期间。